Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on May 28, 2025
Sana Biotechnology to Present at June 2025 Investor Conferences
GlobeNewswire
·
May 28, 2025
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June. …
ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing
GlobeNewswire
·
May 28, 2025
Financing led by SR One and includes participation from new and existing investors, including Point72, Viking Global Investors, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), Nextech, Vivo Capital, and NEXTBio Capital Pro forma cash …
Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
May 28, 2025
DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
GlobeNewswire
·
May 28, 2025
PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …
Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and …
Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult/Adolescent and Pediatric Trials Evaluating TSHA-102
GlobeNewswire
·
May 28, 2025
Natural history data analysis established patients ≥ six years of age are in developmental plateau, with a ~0% likelihood of gaining/regaining developmental milestones across the core functional domains of Rett syndrome Written alignment from FDA supports …
Disc Medicine to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 28, 2025
WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
EyePoint Announces Participation at Upcoming Investor Conferences
GlobeNewswire
·
May 28, 2025
WATERTOWN, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced …
argenx Announces Results of Annual General Meeting of Shareholders
GlobeNewswire
·
May 28, 2025
May 28, 2025 – 10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext …
New Fitness Approach Encourages Training Without Smartphone Distractions
EIN Presswire
·
May 28, 2025
More athletes and trainers embrace smartphone-free workouts to improve focus, boost performance, and enhance training efficiency. NEUMARKT, BAYERN, GERMANY, May 28, 2025 /EINPresswire.com/ -- More and more athletes, trainers, and fitness studios are …
Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
BERKELEY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, …
Dr. Pearlman shares the hottest health and beauty trends from the Red Carpet at the Cannes International Film Festival
EIN Presswire
·
May 28, 2025
Dr. Pearlman was up close to share her leading insights on the top health and beauty trends from the Cote d’Azur this festival season. CANNES, FRANCE, May 28, 2025 /EINPresswire.com/ -- Dr. Jennifer Pearlman, an internationally renowned medical expert …
Board-Certified Orthopedic Surgeon, Dr. Teddy L. Atik Awarded As NJ Top Doc
EIN Presswire
·
May 28, 2025
Teddy Atik, MD, FAAOS of Central Jersey Hand Surgery has been reviewed and approved by NJ Top Docs based on merit for 2025. EATONTOWN, NJ, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Teddy Atik, MD, FAAOS of Central Jersey Hand Surgery has been …
NY Top Docs Approves Somers Orthopaedic Surgery & Sports Medicine Group For 2025
EIN Presswire
·
May 28, 2025
NY Top Docs has reviewed and approved 13 specialists at Somers Orthopaedic Surgery …
Tuberculous Meningitis Treatment Market Forecasted to Reach USD 339,092.8 Million by 2035 at a CAGR of 7% | FMI
EIN Presswire
·
May 28, 2025
Global tuberculous meningitis treatment market poised for growth with rising incidence, improved diagnostics, and targeted therapies NEWARK, DE, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- The global tuberculous meningitis treatment market is …
Aurora Spine Corporation to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 28, 2025
CARLSBAD, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced it will …
Alfa Chemistry Unveils a Comprehensive Food Nutrition Analysis Service Dedicated to Food Manufacturers
EIN Presswire
·
May 28, 2025
New testing service delivers fast, reliable, and FDA-aligned nutrition data to support food labeling compliance and product development NEW YORK, NY, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- The global analytical testing provider Alfa Chemistry …
Exophthalmos Treatment Market Poised to Surpass USD 318.2 Million by 2035 Amid Surge in Thyroid Eye Disease | FMI
EIN Presswire
·
May 28, 2025
Exophthalmos Treatment Market to Witness Significant Growth Driven by Rising Disease Prevalence and Advanced Therapeutic Innovations NEWARK, DE, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- The global exophthalmos treatment market is projected to …
Prosthetics and Orthotics Market to Surpass USD 13,300.5 Million by 2035, Driven by Rising Healthcare Demand | FMI
EIN Presswire
·
May 28, 2025
Global prosthetics and orthotics market poised for robust growth driven by rising amputations, technological innovation, and aging population trends NEWARK, DE, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- The global prosthetics and orthotics …
Thumbay University Hospital Achieves Surgical Milestones in the Northern Emirates
EIN Presswire
·
May 28, 2025
Thumbay University Hospital in Ajman reports notable surgical advancements, including a complex minimally invasive Surgery AJMAN, AJMAN, UNITED ARAB EMIRATES, May 28, 2025 /EINPresswire.com/ -- Thumbay University Hospital in Ajman, one of the region's …